CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($) $ in Millions	9 Months Ended
	Oct. 30, 2020	Nov. 01, 2019
Cash flows from operating activities:
Net income	$ 2,162	$ 5,113
Adjustments to reconcile net income to net cash provided by (used in) operating activities:
Depreciation and amortization	4,017	4,608
Stock-based compensation expense	1,219	886
Deferred income taxes	(219)	(5,927)
Other, net	(322)	866
Changes in assets and liabilities, net of effects from acquisitions and dispositions:
Accounts receivable	885	800
Financing receivables	(624)	(592)
Inventories	(198)	364
Other assets and liabilities	(2,175)	(2,445)
Accounts payable	(216)	299
Deferred revenue	1,001	1,811
Change in cash from operating activities	5,530	5,783
Cash flows from investing activities:
Purchases of investments	(296)	(142)
Maturities and sales of investments	98	449
Capital expenditures and capitalized software development costs	(1,584)	(1,876)
Acquisition of businesses and assets, net	(405)	(2,437)
Divestitures of businesses and assets, net	2,187	(3)
Other	26	27
Change in cash from investing activities	26	(3,982)
Cash flows from financing activities:
Proceeds from the issuance of common stock	389	451
Repurchases of parent common stock	(240)	(6)
Repurchases of subsidiary common stock	(890)	(1,686)
Proceeds from debt	14,772	17,656
Repayments of debt	(17,244)	(18,948)
Other	(270)	(67)
Change in cash from financing activities	(3,483)	(2,600)
Effect of exchange rate changes on cash, cash equivalents, and restricted cash	(67)	(100)
Change in cash, cash equivalents, and restricted cash	2,006	(899)
Cash, cash equivalents, and restricted cash at beginning of the period	10,151	10,240
Cash, cash equivalents, and restricted cash at end of the period	$ 12,157	$ 9,341